Bill Text: NY A03760 | 2013-2014 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Requires health insurance policies to cover comprehensive screening for ovarian cancer.

Spectrum: Moderate Partisan Bill (Democrat 25-4)

Status: (Introduced - Dead) 2013-11-20 - enacting clause stricken [A03760 Detail]

Download: New_York-2013-A03760-Introduced.html
                           S T A T E   O F   N E W   Y O R K
       ________________________________________________________________________
                                         3760
                              2013-2014 Regular Sessions
                                 I N  A S S E M B L Y
                                   January 29, 2013
                                      ___________
       Introduced  by M. of A. ESPINAL -- read once and referred to the Commit-
         tee on Insurance
       AN ACT to amend the insurance  law,  in  relation  to  requiring  health
         insurance policies to cover comprehensive ultrasound screening, genet-
         ic  testing,  magnetic  resonance imaging and/or other screening tests
         for breast cancer in certain cases, requiring the provision of certain
         information relating to breast  density  to  patients;  and  requiring
         health  insurance  policies  to  cover comprehensive tests for ovarian
         cancer in certain cases
         THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
       BLY, DO ENACT AS FOLLOWS:
    1    Section  1.  Paragraph  11  of  subsection  (i) of section 3216 of the
    2  insurance law is amended by adding a new subparagraph  (F)  to  read  as
    3  follows:
    4    (F)  (I)  SUCH POLICY SHALL PROVIDE ADDITIONAL COVERAGE FOR COMPREHEN-
    5  SIVE ULTRASOUND SCREENING, GENETIC TESTING, MAGNETIC  RESONANCE  IMAGING
    6  (MRI),  AND/OR OTHER SCREENING TESTS APPROVED BY THE AMERICAN COLLEGE OF
    7  RADIOLOGY OF AN ENTIRE BREAST OR THE ENTIRETY OF BOTH BREASTS IF:
    8    (I) A MAMMOGRAM DEMONSTRATES  HETEROGENEOUS  OR  DENSE  BREAST  TISSUE
    9  BASED ON THE BREAST IMAGING REPORTING AND DATA SYSTEM ESTABLISHED BY THE
   10  AMERICAN COLLEGE OF RADIOLOGY; OR
   11    (II) A WOMAN IS BELIEVED TO BE AT INCREASED RISK FOR BREAST CANCER DUE
   12  TO  FAMILY  HISTORY OR PRIOR PERSONAL HISTORY OF BREAST CANCER, POSITIVE
   13  GENETIC TESTING OR OTHER  INDICATIONS  AS  DETERMINED  BY  SUCH  WOMAN'S
   14  PHYSICIAN OR NURSE PRACTITIONER.
   15    (II) SUCH ADDITIONAL COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND
   16  COINSURANCE  AS  MAY  BE DEEMED APPROPRIATE BY THE SUPERINTENDENT AND AS
   17  ARE CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A  GIVEN
   18  POLICY.
   19    (III)  EACH  MAMMOGRAPHY  REPORT  PROVIDED  TO A PATIENT SHALL INCLUDE
   20  INFORMATION ABOUT BREAST DENSITY, BASED ON THE BREAST IMAGING  REPORTING
        EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                             [ ] is old law to be omitted.
                                                                  LBD06910-02-3
       A. 3760                             2
    1  AND  DATA SYSTEM ESTABLISHED BY THE AMERICAN COLLEGE OF RADIOLOGY. WHERE
    2  APPLICABLE, SUCH REPORT SHALL INCLUDE THE  FOLLOWING  NOTICE:  "IF  YOUR
    3  MAMMOGRAM  DEMONSTRATES  THAT  YOU HAVE DENSE BREAST TISSUE, WHICH COULD
    4  HIDE SMALL ABNORMALITIES, YOU MIGHT BENEFIT FROM SUPPLEMENTARY SCREENING
    5  TESTS,  DEPENDING ON YOUR INDIVIDUAL RISK FACTORS AND THE RECOMMENDATION
    6  OF YOUR  INTERPRETING PHYSICIAN. A REPORT OF YOUR  MAMMOGRAPHY  RESULTS,
    7  WHICH  CONTAINS  INFORMATION ABOUT YOUR BREAST DENSITY, HAS BEEN SENT TO
    8  YOUR TREATING PHYSICIAN'S OFFICE AND YOU SHOULD  CONTACT  YOUR  TREATING
    9  PHYSICIAN IF YOU HAVE ANY QUESTIONS OR CONCERNS ABOUT YOUR REPORT."
   10    S  2.  Paragraph 11 of subsection (l) of section 3221 of the insurance
   11  law is amended by adding a new subparagraph (F) to read as follows:
   12    (F) (I) SUCH POLICY SHALL PROVIDE ADDITIONAL COVERAGE  FOR  COMPREHEN-
   13  SIVE  ULTRASOUND  SCREENING, GENETIC TESTING, MAGNETIC RESONANCE IMAGING
   14  (MRI), AND/OR OTHER SCREENING TESTS APPROVED BY THE AMERICAN COLLEGE  OF
   15  RADIOLOGY OF AN ENTIRE BREAST OR THE ENTIRETY OF BOTH BREASTS IF:
   16    (I)  A  MAMMOGRAM  DEMONSTRATES  HETEROGENEOUS  OR DENSE BREAST TISSUE
   17  BASED ON THE BREAST IMAGING REPORTING AND DATA SYSTEM ESTABLISHED BY THE
   18  AMERICAN COLLEGE OF RADIOLOGY; OR
   19    (II) A WOMAN IS BELIEVED TO BE AT AN INCREASED RISK FOR BREAST  CANCER
   20  DUE  TO FAMILY HISTORY OR PRIOR PERSONAL HISTORY OF BREAST CANCER, POSI-
   21  TIVE GENETIC TESTING OR OTHER INDICATIONS AS DETERMINED BY SUCH  WOMAN'S
   22  PHYSICIAN OR NURSE PRACTITIONER.
   23    (II) SUCH ADDITIONAL COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND
   24  COINSURANCE  AS  MAY  BE DEEMED APPROPRIATE BY THE SUPERINTENDENT AND AS
   25  ARE CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A  GIVEN
   26  POLICY.
   27    (III)  EACH  MAMMOGRAPHY  REPORT  PROVIDED  TO A PATIENT SHALL INCLUDE
   28  INFORMATION ABOUT BREAST DENSITY, BASED ON THE BREAST IMAGING  REPORTING
   29  AND  DATA SYSTEM ESTABLISHED BY THE AMERICAN COLLEGE OF RADIOLOGY. WHERE
   30  APPLICABLE, SUCH REPORT SHALL INCLUDE THE  FOLLOWING  NOTICE:  "IF  YOUR
   31  MAMMOGRAM  DEMONSTRATES  THAT  YOU HAVE DENSE BREAST TISSUE, WHICH COULD
   32  HIDE SMALL ABNORMALITIES, YOU MIGHT BENEFIT FROM SUPPLEMENTARY SCREENING
   33  TESTS, DEPENDING ON YOUR INDIVIDUAL RISK FACTORS AND THE  RECOMMENDATION
   34  OF  YOUR  INTERPRETING  PHYSICIAN. A REPORT OF YOUR MAMMOGRAPHY RESULTS,
   35  WHICH CONTAINS INFORMATION ABOUT YOUR BREAST DENSITY, HAS BEEN  SENT  TO
   36  YOUR  TREATING  PHYSICIAN'S  OFFICE AND YOU SHOULD CONTACT YOUR TREATING
   37  PHYSICIAN IF YOU HAVE ANY QUESTIONS OR CONCERNS ABOUT YOUR REPORT."
   38    S 3. Subsection (p) of section 4303 of the insurance law is amended by
   39  adding a new paragraph 5 to read as follows:
   40    (5) (A) SUCH COVERAGE SHALL PROVIDE ADDITIONAL COVERAGE FOR COMPREHEN-
   41  SIVE ULTRASOUND SCREENING, GENETIC TESTING, MAGNETIC  RESONANCE  IMAGING
   42  (MRI),  AND/OR OTHER SCREENING TESTS APPROVED BY THE AMERICAN COLLEGE OF
   43  RADIOLOGY OF AN ENTIRE BREAST OR THE ENTIRETY OF BOTH BREASTS IF:
   44    (I) A MAMMOGRAM DEMONSTRATES  HETEROGENEOUS  OR  DENSE  BREAST  TISSUE
   45  BASED ON THE BREAST IMAGING REPORTING AND DATA SYSTEM ESTABLISHED BY THE
   46  AMERICAN COLLEGE OF RADIOLOGY; OR
   47    (II) A WOMAN IS BELIEVED TO BE AT INCREASED RISK FOR BREAST CANCER DUE
   48  TO  FAMILY  HISTORY OR PRIOR PERSONAL HISTORY OF BREAST CANCER, POSITIVE
   49  GENETIC TESTING OR OTHER  INDICATIONS  AS  DETERMINED  BY  SUCH  WOMAN'S
   50  PHYSICIAN OR NURSE PRACTITIONER.
   51    THE  ADDITIONAL  COVERAGE REQUIRED IN THIS SUBPARAGRAPH MAY BE SUBJECT
   52  TO ANNUAL DEDUCTIBLES AND COINSURANCE AS MAY BE  DEEMED  APPROPRIATE  BY
   53  THE  SUPERINTENDENT  AND  AS  ARE  CONSISTENT WITH THOSE ESTABLISHED FOR
   54  OTHER BENEFITS WITHIN A GIVEN POLICY.
   55    (B) EACH MAMMOGRAPHY REPORT PROVIDED TO A PATIENT SHALL INCLUDE INFOR-
   56  MATION ABOUT BREAST DENSITY, BASED ON THE BREAST IMAGING  REPORTING  AND
       A. 3760                             3
    1  DATA  SYSTEM  ESTABLISHED  BY  THE  AMERICAN COLLEGE OF RADIOLOGY. WHERE
    2  APPLICABLE, SUCH REPORT SHALL INCLUDE THE  FOLLOWING  NOTICE:  "IF  YOUR
    3  MAMMOGRAM  DEMONSTRATES  THAT  YOU HAVE DENSE BREAST TISSUE, WHICH COULD
    4  HIDE SMALL ABNORMALITIES, YOU MIGHT BENEFIT FROM SUPPLEMENTARY SCREENING
    5  TESTS,  DEPENDING ON YOUR INDIVIDUAL RISK FACTORS AND THE RECOMMENDATION
    6  OF YOUR INTERPRETING PHYSICIAN. A REPORT OF  YOUR  MAMMOGRAPHY  RESULTS,
    7  WHICH  CONTAINS  INFORMATION ABOUT YOUR BREAST DENSITY, HAS BEEN SENT TO
    8  YOUR TREATING PHYSICIAN'S OFFICE AND YOU SHOULD  CONTACT  YOUR  TREATING
    9  PHYSICIAN IF YOU HAVE ANY QUESTIONS OR CONCERNS ABOUT YOUR REPORT."
   10    S  4.  Paragraph  7 of subsection (d) of section 4326 of the insurance
   11  law, as added by chapter 1 of the laws of 1999, is amended  to  read  as
   12  follows:
   13    (7) adult preventive health services consisting of mammography screen-
   14  ing,  AS  PROVIDED  IN  SUBSECTION  (P)  OF  SECTION FOUR THOUSAND THREE
   15  HUNDRED THREE OF THIS ARTICLE; OVARIAN CANCER SCREENING AS  PROVIDED  IN
   16  SUBSECTION  (P-1)  OF  SECTION FOUR THOUSAND THREE HUNDRED THREE OF THIS
   17  ARTICLE; cervical cytology screening; periodic physical examinations  no
   18  more than once every three years; and adult immunizations;
   19    S 5. Subsection (i) of section 3216 of the insurance law is amended by
   20  adding a new paragraph 11-b to read as follows:
   21    (11-B)  (A) EVERY POLICY THAT PROVIDES COVERAGE FOR HOSPITAL, SURGICAL
   22  OR MEDICAL CARE SHALL PROVIDE THE FOLLOWING COVERAGE FOR  SCREENING  FOR
   23  OVARIAN CANCER:
   24    (I)  UPON  THE  RECOMMENDATION  OF A PHYSICIAN, A PELVIC EXAM, GENETIC
   25  TESTING, ULTRASOUND AND BLOOD TESTING AT ANY  AGE  FOR  COVERED  PERSONS
   26  HAVING  A  HIGH  RISK  OF  DEVELOPING OVARIAN CANCER OR WHO HAVE A FIRST
   27  DEGREE RELATIVE WITH A PRIOR HISTORY OF OVARIAN CANCER;
   28    (II) A SINGLE BASELINE ULTRASOUND FOR COVERED PERSONS AGED THIRTY-FIVE
   29  THROUGH THIRTY-NINE, INCLUSIVE; AND
   30    (III) AN ANNUAL ULTRASOUND FOR COVERED PERSONS AGED FORTY AND OLDER.
   31    (B) SUCH COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF THIS  PARA-
   32  GRAPH  MAY  BE  SUBJECT  TO ANNUAL DEDUCTIBLES AND COINSURANCE AS MAY BE
   33  DEEMED APPROPRIATE BY THE SUPERINTENDENT  AND  AS  ARE  CONSISTENT  WITH
   34  THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN POLICY.
   35    (C) (I) SUCH POLICY SHALL PROVIDE FOR ADDITIONAL COVERAGE FOR COMPUTED
   36  TOMOGRAPHY, BARIUM ENEMA X-RAYS, MAGNETIC RESONANCE IMAGING (MRI), POSI-
   37  TRON  EMISSION  TOMOGRAPHY,  LAPAROSCOPY,  COLONOSCOPY  AND  BIOPSY IF A
   38  PERSON IS BELIEVED TO BE AT INCREASED RISK FOR  OVARIAN  CANCER  DUE  TO
   39  FAMILY  HISTORY  OR  PRIOR  PERSONAL HISTORY OF OVARIAN CANCER, POSITIVE
   40  GENETIC TESTING OR OTHER INDICATIONS  AS  DETERMINED  BY  SUCH  PERSON'S
   41  PHYSICIAN OR NURSE PRACTITIONER.
   42    (II) SUCH ADDITIONAL COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND
   43  COINSURANCE  AS  MAY  BE DEEMED APPROPRIATE BY THE SUPERINTENDENT AND AS
   44  ARE CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A  GIVEN
   45  POLICY.
   46    S 6. Subsection (1) of section 3221 of the insurance law is amended by
   47  adding a new paragraph 11-b to read as follows:
   48    (11-B) (A) EVERY INSURER DELIVERING A GROUP OR BLANKET POLICY OR ISSU-
   49  ING  A  GROUP OR BLANKET POLICY FOR DELIVERY IN THIS STATE THAT PROVIDES
   50  COVERAGE FOR HOSPITAL,  SURGICAL  OR  MEDICAL  CARE  SHALL  PROVIDE  THE
   51  FOLLOWING COVERAGE FOR SCREENING FOR OVARIAN CANCER:
   52    (I)  UPON  THE  RECOMMENDATION  OF A PHYSICIAN, A PELVIC EXAM, GENETIC
   53  TESTING, ULTRASOUND AND BLOOD TESTING AT ANY  AGE  FOR  COVERED  PERSONS
   54  HAVING  A  HIGH  RISK  OF  DEVELOPING OVARIAN CANCER OR WHO HAVE A FIRST
   55  DEGREE RELATIVE WITH A PRIOR HISTORY OF OVARIAN CANCER;
       A. 3760                             4
    1    (II) A SINGLE BASELINE ULTRASOUND FOR COVERED PERSONS AGED THIRTY-FIVE
    2  THROUGH THIRTY-NINE, INCLUSIVE; AND
    3    (III) AN ANNUAL ULTRASOUND FOR COVERED PERSONS AGED FORTY AND OLDER.
    4    (B)  SUCH COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF THIS PARA-
    5  GRAPH MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND  COINSURANCE  AS  MAY  BE
    6  DEEMED  APPROPRIATE  BY  THE  SUPERINTENDENT  AND AS ARE CONSISTENT WITH
    7  THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN POLICY.
    8    (C) (I) SUCH POLICY SHALL PROVIDE FOR ADDITIONAL COVERAGE FOR COMPUTED
    9  TOMOGRAPHY, BARIUM ENEMA X-RAYS, MAGNETIC RESONANCE IMAGING (MRI), POSI-
   10  TRON EMISSION TOMOGRAPHY,  LAPAROSCOPY,  COLONOSCOPY  AND  BIOPSY  IF  A
   11  PERSON  IS  BELIEVED  TO  BE AT INCREASED RISK FOR OVARIAN CANCER DUE TO
   12  FAMILY HISTORY OR PRIOR PERSONAL HISTORY  OF  OVARIAN  CANCER,  POSITIVE
   13  GENETIC  TESTING  OR  OTHER  INDICATIONS  AS DETERMINED BY SUCH PERSON'S
   14  PHYSICIAN OR NURSE PRACTITIONER.
   15    (II) SUCH ADDITIONAL COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND
   16  COINSURANCE AS MAY BE DEEMED APPROPRIATE BY THE  SUPERINTENDENT  AND  AS
   17  ARE  CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN
   18  POLICY.
   19    S 7. Section 4303 of the insurance law is  amended  by  adding  a  new
   20  subsection (p-1) to read as follows:
   21    (P-1)  (1) A MEDICAL EXPENSE INDEMNITY CORPORATION, A HOSPITAL SERVICE
   22  CORPORATION OR A HEALTH SERVICE CORPORATION THAT PROVIDES  COVERAGE  FOR
   23  HOSPITAL,  SURGICAL OR MEDICAL CARE SHALL PROVIDE THE FOLLOWING COVERAGE
   24  FOR SCREENING FOR OVARIAN CANCER:
   25    (A) UPON THE RECOMMENDATION OF A PHYSICIAN,  A  PELVIC  EXAM,  GENETIC
   26  TESTING,  ULTRASOUND  AND  BLOOD  TESTING AT ANY AGE FOR COVERED PERSONS
   27  HAVING A HIGH RISK OF DEVELOPING OVARIAN CANCER  OR  WHO  HAVE  A  FIRST
   28  DEGREE RELATIVE WITH A PRIOR HISTORY OF OVARIAN CANCER;
   29    (B)  A SINGLE BASELINE ULTRASOUND FOR COVERED PERSONS AGED THIRTY-FIVE
   30  THROUGH THIRTY-NINE, INCLUSIVE; AND
   31    (C) AN ANNUAL ULTRASOUND FOR COVERED PERSONS AGED FORTY AND OLDER.
   32    (2) SUCH COVERAGE REQUIRED PURSUANT TO SUBPARAGRAPH (A) OF THIS  PARA-
   33  GRAPH  MAY  BE  SUBJECT  TO ANNUAL DEDUCTIBLES AND COINSURANCE AS MAY BE
   34  DEEMED APPROPRIATE BY THE SUPERINTENDENT  AND  AS  ARE  CONSISTENT  WITH
   35  THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN POLICY.
   36    (3) (A) SUCH POLICY SHALL PROVIDE FOR ADDITIONAL COVERAGE FOR COMPUTED
   37  TOMOGRAPHY, BARIUM ENEMA X-RAYS, MAGNETIC RESONANCE IMAGING (MRI), POSI-
   38  TRON  EMISSION  TOMOGRAPHY,  LAPAROSCOPY,  COLONOSCOPY  AND  BIOPSY IF A
   39  PERSON IS BELIEVED TO BE AT INCREASED RISK FOR  OVARIAN  CANCER  DUE  TO
   40  FAMILY  HISTORY  OR  PRIOR  PERSONAL HISTORY OF OVARIAN CANCER, POSITIVE
   41  GENETIC TESTING OR OTHER INDICATIONS  AS  DETERMINED  BY  SUCH  PERSON'S
   42  PHYSICIAN OR NURSE PRACTITIONER.
   43    (B)  SUCH ADDITIONAL COVERAGE MAY BE SUBJECT TO ANNUAL DEDUCTIBLES AND
   44  COINSURANCE AS MAY BE DEEMED APPROPRIATE BY THE  SUPERINTENDENT  AND  AS
   45  ARE  CONSISTENT WITH THOSE ESTABLISHED FOR OTHER BENEFITS WITHIN A GIVEN
   46  POLICY.
   47    S 8. This act shall take effect on the sixtieth  day  after  it  shall
   48  have become a law.
feedback